Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2003-04-28
2008-03-04
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S025000, C514S456000, C536S004100
Reexamination Certificate
active
07338941
ABSTRACT:
Methods of treating a mammal with high blood-glucose, or high blood-cholesterol, levels with isovitexin, and pharmaceutical compositions comprising the same are disclosed.
REFERENCES:
patent: 0 775 451 (1997-05-01), None
patent: 01179678 (1989-07-01), None
patent: 01179678 (1989-07-01), None
patent: WO 00/59522 (2000-10-01), None
Lamba et al. (Studies in Natural Products chemistry (2000), 21 (Bioactive Natural Products (Part B), 457-496)) (Abstract Sent).
Easa et al. (International journal of Chemistry (1995), 6 (1 &2), 21-25) (Abstract sent).
Vasilenko et al. (Izvestyia Severo-Kavkaskogo Nauchnogo Tsentra Vysshei Shkoly, Estestvennye Nauki (1978), 6(40), 99-101) (Abstract sent).
Rastrelli et al. (Journal of Natural Products (2001), 64 (1), 79-81).
Sharma et al. (European Journal of Clinical Nutrition, (Apr. 1990) 44 (4), pp. 301-306 (Abstract Sent).
Sishadri et al. (Current Science (1973), 43 (12), 421-2) (Abstract Sent).
Abstract of Ramaratonamu et al. , JP 01179678A, Jul. 17, 1989 (Abstract sent).
Bellman et al. (Helvetica Chimica Acta (1973), 56(1), 284-294) (Abstract Sent).
Ramaratonamu et al.; JP 01179678 , Jul. 17, 1989 (Abstract Sent).
Abdel-Barry, J.A. et al., Hypoglycaemic effect of aqueous extract of the leaves of Trigonella foenum-graecum in healthy volunteers, East. Mediterr. Health. J. 6(1):83-88 (2000).
Anila, L. et al., Beneficial effects of flavonoids fromSesamum indicum, Emblica officinalisandMomordica charantia, Phytother. Res. 14(8):592-5 (2000).
Bhardwaj, P.K. et al., Control of hyperglycaemia and hyperlipidaemia by plant product, J. Assoc. Physicians India 42(1):33-35 (1994).
Bhatti, M.A. et al., Antibacterial activity of trigonella foenum-graecum seeds, Fitoterapia 67:372-374 (1996).
Bordia, A. et al., Effect of ginger (Zingiber officinaleRosc.) and fenugreek (Trigonella foenumgraecumL.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease, Prostaglandins Leukot. Essent. Fatty Acids 56(5):379-84 (1997).
Exner, M. et al., Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein, Free Radic. Res. 34(1):101-12 (2001).
Guillot, R. et al. Effect of long-term treatment with a purified micronized flavonoid fraction on pancreatic mononuclear cell infiltration in diabetic BB rats, Pancreas 17(3):301-8 (1998).
Hii, C.S. et al., Effects of epicatechin on rat islets of Langerhans, Diabetes 33(3):291-6 (1984).
Hollman, P.C. et al., The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man, Free Radic. Res. 31(6):569-73 (1999).
Kim, J.S., et al., Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid, Biosci. Biotechnol. Biochem. 64(11):2458-61 (2000).
Kumar, R.V. et al., Antidiabetic effect of a leucocyanidin derivative isolated from the bark ofFicus bengalensislinn., Indian J. Biochem. Biophys. 6:400-4 (1989).
Lean, M.E. et al., Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA, Diabetes 48(1):176-81 (1999).
Lee, S.C. et al., Bioflavonoids commonly and potently induce tyrosine dephosphorylation/inactivation of oncogenic proline-directed protein kinase FA in human prostate carcinoma cells, Anticancer Res. 18(2A):1117-21 (1998).
Lim, S.S. et al., Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues, J. Pharm. Pharmacol. 53(5):653-68 (2001).
Lin, et al., Prevention of cellular ROS damage by isovitexin and related flavonoids, Planta Med. 68:365-367 (2002).
Lonchampt, M. et al., Protective effect of a purified flavonoid fraction against reactive oxygen radicals: In vivo and in vitro study, Arzneimittelforschung. 39(8):882-5 (1989).
Madar, Z. et al., Glucose-lowering effect of fenugreek in non-insulin dependent diabetics, Eur. J. Clin. Nutr. 42(1):51-4 (1988).
Madar, Z. et al., Dietary fiber, Prog. Food Nutr. Sci. 11(2):153-174 (1987).
Madar, Z., New sources of dietary fibre, Int. J. Obes. 11:57-65 (1987).
Morand, C. et al., Respective bioavailability of quercetin aglycone and its glycosides in a rat model, Biofactors 12:169-74 (2000).
Sadhukhan, B. et al., Clinical evaluation of a herbal antidiabetic product, J. Indian Med. Assoc. 92(4):115-7 (1994).
Sakushima, et al., Major antioxidative substances inBoreava orientalis(cruciferae), Natural Product Letters, 14(6):441-446 (2000).
Sharma, R.D. et al., Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes, European Journal of Clinical Nutrition 44:301-6 (1990).
Sharma, R .D. et al, Hypoglycaemic effects of Fenugreek seeds in non-insulin dependent diabetic subjects, Nutrition Research 10:731-79 (1990).
Sharma, R. D. et al., Hypolipidaemic effect of Fenugreek seeds: a chronic study in non-insulin dependent diabetic patients, Phytotherapy Research 10: 332-334 (1996).
Shin, et al., Synthesis and hypoglycemic effect of chrysin derivatives, Bioorganic and Medicinal Chemistry Letters, 9:869-874 (1999).
Soto, et al., Prevention of alloxan-induced diabetes mellitus in the rat by silymarin, Comp. Biochem. Physiol. 119(2):125-9 (1998).
Sowmya, P. et al., Hypocholesterolemic effect of germinated fenugreek seeds in human subjects, Plant Foods Hum. Nutr. 53(4):359-65 (1999).
Totte, et al.,Trigonella foenum-graecuml., Farmaceutisch Tijdschrift Voor Belgie, 60(4):203-215 (1983).
Wang, H.X. et al., Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities, Life Sci. 65(25):2663-77 (1999).
Zenon, G.J. 3rd, et al., Potential use of aldose reductase inhibitors to prevent diabetic complications, Clin. Pharm. 9(6):446-57 (1990).
Bibbs Jeffrey A.
Rao Srirama
Diakron Pharmaceuticals, Inc.
Henry Michael C.
Jiang Shaojia Anna
Knobbe Martens Olson & Bear LLP
LandOfFree
Pharmaceutical compositions for lowering blood glucose and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for lowering blood glucose and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for lowering blood glucose and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3975954